Clinical trial
Prospective, Single-arm, Multicenter Exploratory Clinical Study of the Combination of Etoposide, Cytarabine and PEG-rhG-CSF (EAP Regimen) as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
NCT05536154 is registered in ClinicalTrials.gov with The Affiliated People's Hospital of Ningbo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Single-arm, Multicenter Exploratory Clinical Study of the Combination of Etoposide, Cytarabine and PEG-rhG-CSF (EAP Regimen) as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
- Lead sponsor
- The Affiliated People's Hospital of Ningbo University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 1, 2022
- Completion date
- October 31, 2024
- Enrollment
- 68 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.